Shares of Cardio Diagnostics Holdings, Inc. (CDIO), an artificial intelligence-powered precision cardiovascular medicine company, are rising nearly 150% Tuesday morning following the launch of PrecisionCHD, a blood test for the early detection of coronary heart disease.
PrecisionCHD, a non-invasive test detects coronary heart disease with better than 75% sensitivity in both men and women. the company said.
CDIO is at $3.15 currently. It has traded in the range of $0.79-$10.25 in the last 1 year.
Source: Read Full Article
Lates News:
-
‘Diamond Hands’ Tesla Still HODLing Over 10,000 BTC, Q4 2022 Report Reveals
-
Binance Secures First Full Crypto Exchange Licenses in El Salvador
-
Daseke Ascends 14% On Decision To Buy Back Founder’s Stake
-
Alstom FY23 Loss Narrows, Sees Growth Next Year; Delays Mid Term View; Stock Dips
-
Ally Financial Adds 13% As Revenue Rises, Earnings Beat